MedPath
NMPA Approval

Loxoprofen Sodium Oral Solution

国药准字H20253586

March 11, 2025

Drug Information

洛索洛芬钠口服溶液

口服溶液剂

10ml:60mg(按C₁₅H₁₇NaO₃计)

化学药品

March 11, 2025

Company Information

Applicant Company

福建省三明市三元区台江路46号

Manufacturing Company

浙江省金华市婺城区汤溪镇永湖街788号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

洛索洛芬钠口服溶液 - NMPA 批准文号 | MedPath